✦ LIBER ✦

HCV RNA Viral Load Assessments in the Era of Direct-Acting Antivirals

✍ Scribed by Cobb, Bryan; Pockros, Paul J; Vilchez, Regis A; Vierling, John M

Book ID: 120369937
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 274 KB
Volume: 108
Category: Article
ISSN: 0002-9270
DOI: 10.1038/ajg.2012.248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Liver Biopsy in the Era of Direc

Role of Liver Biopsy in the Era of Direct-Acting Antivirals

✍ Gonzalez, Humberto C.; Jafri, Syed Mohammed; Gordon, Stuart C 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 192 KB

Current race in the development of DAAs

Current race in the development of DAAs (direct-acting antivirals) against HCV

✍ De Clercq, Erik 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Current race in the development of DAAs

Current race in the development of DAAs (direct-acting antivirals) against HCV

✍ De Clercq, Erik 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 472 KB

The direct-acting antivirals (DAAs) currently in development for treatment of hepatitis C fall into four categories: (i) NS3/4A protease inhibitors: ABT-450/r, faldaprevir, asunaprevir, GS-9256, vedroprevir (GS-9451), danoprevir, MK-5172, vaniprevir, sovaprevir, ACH-2684, narlaprevir and simeprevir,

Hepatitis C: Management of Side Effects

Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals

✍ John N. Gaetano, Nancy Reau 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 156 KB

Hepatitis C virus and lipids in the era

Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)

✍ Sheridan, David A.; Neely, R. Dermot G.; Bassendine, Margaret F. 📂 Article 📅 2013 🏛 Elsevier 🌐 French ⚖ 382 KB

Managing HIV/hepatitis C co-infection in

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals

✍ Rockstroh, Jürgen K; Bhagani, Sanjay 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 228 KB